Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Polycystic Ovary Syndrome 2Metabolic Syndrome 2Carcinoma, Non-Small-Cell Lung 2Sleep Apnea, Obstructive 1Pancreatic Neoplasms 1Leukoplakia, Oral 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Insulin Resistance 1Inflammation 1Hypogonadism 1Glucose Intolerance 1Diabetes Mellitus 1

Interventions

Surveys and Questionnaires 1Pioglitazone 1Photochemotherapy 1Aminolevulinic Acid 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Leukoplakia, Oral × Pioglitazone × Clear all
NCT00951379 2016-04-06

Pioglitazone for Oral Premalignant Lesions

National Cancer Institute (NCI)

Phase 2 Terminated
52 enrolled 23 charts
Head & Neck

Leukoplakia, Oral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡